... Nov 03
It is a sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis (MS).... Jun 24
The approval confirms Aubagio as the first oral multiple sclerosis (MS) therapy for first-line treatment of children and adolescents with MS in the European ... Jun 19
FDA is taking an initiative to authorize the marketing of Portable Neuromodulation Stimulator (PoNS) for Multiple Sclerosis patients which can help patients with their motor ... Apr 15
Shorter infusion time will further improve the twice-yearly treatment experience for OCREVUS, the only B-cell therapy for relapsing and primary progressive MS with ... Dec 15
After Dr Reddy's, Lupin Ltd. also launches Dimethyl Fumarate Delayed-Release Capsules... Oct 06
Dimethyl Fumarate Capsules are indicated for the treatment of multiple sclerosis... Sep 25
Cipla Limited today announced that it has received final approval for its ANDA for Dimethyl Fumarate Capsules... Sep 25
-Advertisements-
Wednesday, May 15, 2024
.jpeg)
